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Abstract
Background: Outcome measurement plays an increasing role in improving the quality, effectiveness, efficiency and availability of 
palliative care.
Aim: To provide expert recommendations on outcome measurement in palliative care in clinical practice and research.
Methods: Developed by a European Association for Palliative Care Task Force, based on literature searches, international expert 
workshop, development of outcome measurement guidance and international online survey. A subgroup drafted a first version and 
circulated it twice to the task force. The preliminary final version was circulated to wider expert panel and 28 international experts 
across 20 European Association for Palliative Care member associations and the European Association for Palliative Care Board of 
Directors and revised according to their feedback. The final version was approved by the European Association for Palliative Care 
Board for adoption as an official European Association for Palliative Care position paper.
Results: In all, 12 recommendations are proposed covering key parameters of measures, adequate measures for the task, introduction 
of outcome measurement into practice, and national and international outcome comparisons and benchmarking. Compared to other 
recommendations, the White Paper covers similar aspects but focuses more on outcome measurement in clinical care and the wider 
policy impact of implementing outcome measurement in clinical palliative care. Patient-reported outcome measure feedback improves 
awareness of unmet need and allows professionals to act to address patients’ needs. However, barriers and facilitators have been 
identified when implementing outcome measurement in clinical care that should be addressed.
Conclusion: The White Paper recommends the introduction of outcome measurement into practice and outcomes that allow for 
national and international comparisons. Outcome measurement is key to understanding different models of care across countries and, 
ultimately, patient outcome having controlled for differing patients characteristics.
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Background
Outcome measurement plays an increasing role in improv-
ing the quality, effectiveness, efficiency and availability 
of palliative care. Until recently, almost all assessments of 
the quality of palliative care focused on care structures 
and processes rather than on outcomes. Outcome meas-
ures are widely used in palliative care research to describe 
patient populations or to assess the effectiveness of inter-
ventions, but they are not, as yet, always incorporated into 
routine clinical practice.1 Where they have been intro-
duced routinely into practice with timely feedback loops, 
there is evidence of improved patient outcomes at a sys-
tems level.2
Patient-reported outcomes position patients at the cen-
tre of care and help professionals to focus on what matters 
to patients and families. Funding from government or 
commissioners is also becoming conditional on the provi-
sion of patient-centred outcomes data in an increasing 
number of countries.3 Accordingly, services need to 
improve how they communicate about their outcomes as 
this may ensure continued funding and ongoing support.1
To move outcome measurement in palliative care for-
ward internationally, the European Union (EU)-funded 
PRISMA (Reflecting the Positive diveRsities of European 
prIorities for reSearch and Measurement in end of life 
cAre) project (2009–2011) focused on promoting best prac-
tice in the measurement of end-of-life care.4 Central activi-
ties included literature scoping to identify resources for 
standardised outcome measures in palliative care in clinical 
care and research5 and an international online survey on 
palliative care professionals’ experiences with outcome 
measurement identifying the high need of professionals for 
training and guidance and the lack of agreement on which 
tools to use.6–8 An international expert workshop on outcome 
measurement with 32 professionals from 15 countries under-
pinned the need for standardisation with improvement of 
existing patient-reported outcome measures (PROMs), the 
What is already known about the topic?
•• Outcome measurement and especially patient-reported outcome measurement is gaining increasing attention in palliative 
care to assess the quality, effectiveness, efficiency and availability of palliative care.
What this paper adds?
•• Key recommendations by the European Association for Palliative Care (EAPC) Task Force on Outcome Measurement on 
use, choice and implementation of outcome measures and use of outcomes for national and international comparisons and 
benchmarking in clinical care and research.
Implications for practice, theory or policy
•• Outcome measurement is key to understanding different models and commonalities of care across countries and patient 
complexity. The use of individual patient-reported data will substantiate the clinically meaningful difference palliative care 
makes. Outcome data are also essential to quality improvement, benchmarking and comparisons within Europe.
aspects of further development with a multiprofessional 
approach taking into account cultural sensitivity especially 
for translated versions and the need for guidance, training 
and resources.9 This leads finally to the development of 
guidance for professionals about outcome measurement in 
general and the specifics of palliative care and the imple-
mentation and use of outcome measures in palliative care.10 
The Methods Of Researching End of life Care (MORECare) 
project intended to develop evidence-based guidance on 
the best methods for the design and conduct of research on 
end-of-life care and generated recommendations and con-
sensus for research in palliative and end-of-life care on the 
properties of the best outcome measures.11,12 In the United 
States, a number of projects focused on outcome measure-
ment in clinical trials, for example, the International Society 
for Quality of Life Research (ISOQOL)13 or the Patient-
Reported Outcomes Measurement Information System 
(PROMIS).14
Based on the PRISMA work and other international 
developments, the purpose of this European Association 
for Palliative Care (EAPC) White Paper is to provide 
expert recommendations on outcome measurement in pal-
liative care in clinical practice and research in order to 
attain excellent quality of care for patients and their unpaid 
caregivers (families and others), to ensure continued pro-
vision of palliative care services and to advance the field 
of palliative care.
Methods
This White Paper was developed between 2011 and 2013 
by the Task Force on Outcome Measurement of the EAPC 
consisting of 14 members from 11 countries, including 
medical, nursing and allied health disciplines. The mem-
bers were chosen as they had clinical and/or research 
expertise in outcome measurement. Together, they formed 
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a multiprofessional team and represented a number of 
large international outcome measurement consortia 
(PRISMA,4 MoreCARE,12 European Palliative Care 
Research Collaborative (EPCRC),15 Palliative Care 
Outcome Collaborative (PCOC),16 German outcome 
project17).
At the first meeting of the task force at the EAPC con-
ference in Lisbon in 2011, 11 task force members (AC, 
AA, BD, CB, DC, IH, JD, LD, LR, MC and SK) were 
present starting an informal discussion about the potential 
structure and content of the White Paper. Based on this 
discussion, a remit was developed for the White Paper by 
a mandated writing committee of task force members (CB, 
BD, DC, LR, LD, JD and KD) including the intended tar-
get group, the scope of the paper and a suggested structure 
with assigned authors of the writing group for subsections 
of the paper. The remit was circulated to the whole task 
force for further feedback. The writing committee collated 
individual sections and produced a first draft of the paper. 
This was circulated to the whole task force via email for 
written feedback. Minor comments were integrated in the 
paper. Substantial comments such as number and wording 
of recommendations, length of document, overall content 
and practice examples were discussed at the second meet-
ing of the Task Force in Trondheim in 2012 with nine task 
force members being present (CB, JD, BD, SK, DC, MC, 
LR, IH and RH). No formal consensus process was fol-
lowed in this discussion. A revised version (CB and BD) 
including the results of the Trondheim discussion was cir-
culated again to the whole task force for final feedback and 
agreement within the task force. A preliminary final ver-
sion was then circulated to a wider expert panel on out-
come measurement with 28 international experts across 20 
member associations of the EAPC and the EAPC Board of 
Directors asking for comments focusing on three main 
issues relating to the paper. A total of 18 countries from 
Europe and the United States were represented by the 
experts. Experts were chosen based on their experience 
using PROMs either in clinical care or research in pallia-
tive care (e.g. publications, participation in international 
collaborations). The writing group discussed the written 
feedback from 21 experts and produced a final version of 
the White Paper (08-11/2012) which was approved by the 
EAPC Board of Directors for adoption as an official EAPC 
position paper in October 2013.
As many issues in outcome measurement relate to clini-
cal care and research, the recommendations are written for 
both areas, and only when they relate to one or the other is 
it specifically mentioned (Table 1).
Recommendations on outcome 
measurement in palliative care
Recommendation 1: Use PROMs that have been vali-
dated with relevant populations requiring palliative 
care and make sure these are sufficiently brief and 
straightforward and that they allow for proxy reports 
when the patient is unable to self-report
Patients across malignant and non-malignant diseases, for 
example, chronic heart, lung or neurological disease, suffer 
from multiple palliative care needs that are similar irrespec-
tive of the underlying life-limiting illness. PROMs/PROs 
capture the patient’s subjective perception of symptoms and 
psychological, social and spiritual concerns and are regarded 
as the ‘gold standard’ in palliative care. PROMs are stand-
ardised, validated questionnaires of which many have been 
developed for the assessment of treatment effectiveness.20
Generic measures are multidimensional measures 
assessing multi-faceted aspects of a person’s health includ-
ing physical, psychological and social components. They 
can be used on a large range of health and quality of life 
concepts, and in various health conditions, populations 
and interventions. Examples of generic measures are the 
36-item Short-Form Health Survey (SF-36),21 EuroQOL 
Five Dimensions Questionnaire (EQ-5D),22 General 
Health Questionnaire (GHQ)23 or Sickness Impact 
Profile.24 Most of these measures are not yet validated in 
palliative care, although several of them have been used in 
fields allied to palliative care but not within palliative care.
Specific measures are designed for particular domains, 
health conditions, signs and symptoms, body parts or popu-
lations. Most outcome and quality of life measures are spe-
cific measures.25 Palliative care–specific examples are the 
Palliative care Outcome Scale (POS) (www.pos-pal.org),26 
the Edmonton Symptom Assessment Scale (ESAS)27 or 
the EORTC QLQ-C15-PAL European Organisation for 
Research and Treatment of Cancer Quality of Life 
Questionnaire Core 15 Palliative.28 Symptom-specific 
measures focus on one particular symptom either as uni-
dimensional scales assessing the severity or distress caused 
by a symptom (e.g. with a Visual Analogue Scale (VAS) or 
Numerical Rating Scale (NRS)) or as multidimensional 
scales (e.g. Brief Pain Inventory29). Symptom-specific 
measures capture severity alongside interference with other 
symptoms. They can also measure how symptoms impact 
on quality of life in general as well as their impact on role 
performance. Specific measures validated in populations 
requiring palliative care are ideal for use in this field.
Many of the measures developed for palliative care are 
free to use, although sometimes registration is necessary. 
This is important as professionals have stated that cost is a 
major issue when considering which tool to use.8 Also, 
instrument developers and software developers are push-
ing for copyrighted instruments, many of which then incur 
ongoing costs for use.
Illness, cognitive impairment and deterioration during 
the dying phase make PROMs challenging to use in pallia-
tive care, and patients are often unable to complete lengthy 
measures. Therefore, measures must be sufficiently brief 
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and straightforward to aid comprehension and completion. 
Even for short and straightforward measures, patients may 
become unable to complete assessments. In this instance, 
proxy assessments provide an alternative source of infor-
mation.30 Proxy assessments are reports by someone else 
other than the patient, for example, a healthcare profes-
sional or a family caregiver. Proxy reports are particularly 
helpful during the terminal days and hours of life, as fam-
ily members and others close to the patient can provide 
valuable insight into changes that may be occurring.
Although there are benefits involved with proxy reports, 
evidence about the accuracy of proxy ratings is conflicting 
because of differences between patient self-completed, cli-
nician and family reports of symptoms. Compared to 
patient’s self-reports, clinicians under-estimate31 and 
spouses or partners over-estimate the severity of some 
symptoms.32 Overall, there seems to be more agreement 
concerning the more overt symptoms and aspects of the 
patient’s functioning, for example, immobility, activities 
of daily living and for some symptoms such as fatigue, 
dyspnoea and vomiting, whereas agreement is poorer for 
more latent aspects of the patient’s experience like pain, 
the patient’s feelings and thoughts.33 Ideally, measures that 
have evidence to show the comparability between patient 
and proxy reports are best as this will help with outcome 
measurement with patients and their families throughout 
the whole course of care right through until death.34,35
Recommendation 2: Use multidimensional measures 
that capture the holistic nature of palliative care
As palliative care aims to provide holistic care for patients 
and families, outcome measures used by generalist and 
specialist palliative care providers should ideally cover 
several domains including physical (e.g. physical symp-
toms and functional status), psychological (e.g. cognition 
and emotions), social and cultural (e.g. family and friends, 
organisational and financial) and spiritual (e.g. beliefs, 
meaning and religion) domains. Multidimensional 
measures – such as the ESAS or POS – can be supplemented 
Table 1. Definitions and recommendations.
Definitions
An outcome is ‘the change in a patient’s current and future health status that can be attributed to preceding healthcare’.18
Outcome measurement involves the use of a valid and reliable measure to establish a patient’s baseline health status and then 
evaluating changes over time against that baseline. Outcome measurement is an important step to measure the value of health care 
provided.19
Key parameters of measures
Recommendation 1: Use patient-reported outcome measures (PROMs) that have been validated with relevant populations requiring 
palliative care and make sure these are sufficiently brief and straightforward and that they allow for proxy reports to be collected 
for when the patient is unable to self-report.
Recommendation 2: Use multidimensional measures that capture the holistic nature of palliative care.
Recommendation 3: Use outcome measures to assess the needs of unpaid caregivers (family and others) alongside the needs of 
patients.
Recommendation 4: Use measures that have sound psychometric properties.
Adequate measure for the task
Recommendation 5: Use measures that are suited to the clinical task being delivered and also suited to the aims of your clinical 
work and the population you work with.
Recommendation 6: Use valid and reliable measures in research that are relevant to the research question and consider patient 
burden when using measures.
Introduction of outcome measurement into practice
Recommendation 7: Use change management principles, facilitation and communication to embed outcome measurement into 
routine clinical practice and evaluate the implementation process to ensure sustained use that penetrates practice within the 
organisation.
National and international: outcome comparisons and benchmarking
Recommendation 8: Relate outcome measurement to quality indicators.
Recommendation 9: Establish and use quality improvement systems to sustain routine practice of outcome measurement and 
institute interoperable electronic systems to ensure integration of measures and across settings.
Recommendation 10: Use measures that allow for comparisons across care settings and throughout Europe. Therefore, use 
measures that are culturally sensitive and have validated translations in relevant languages/countries.
Recommendation 11: Advance the field of palliative and end-of-life care through establishing national and international outcome 
collaborations that work towards benchmarking to establish and improve care standards.
Recommendation 12: To improve and monitor palliative care practice, policy makers should recommend routine collection of 
outcome data, and then these data should be used to establish a minimum dataset of palliative care outcome measures in order to 
improve and advance clinical care and research.
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by add-on measures that allow for more in-depth investi-
gation of specific dimensions that the patient identified as 
problematic.
For the clinical setting, multiple symptoms should be 
included in the measure in order to assess the full experi-
ence and symptom burden of the patient. One key reason 
for asking about a number of symptoms is that there are 
symptoms that patients are less likely to volunteer, unless 
specifically asked.36,37 In this respect, having measures 
that ask patients to volunteer what matters to them is use-
ful. For research, measures focusing on one particular 
symptom are often chosen, when the study is focused on 
the management of that symptom.
Patients suffering from advanced disease face physical 
decline towards the end of life. Maintaining their inde-
pendence for as long as possible is paramount in palliative 
care. Outcome measures such as the Australian-modified 
Karnofsky38 or the Barthel Index39 capture function and 
are already used in palliative care.40,41
Advanced disease also has an impact on a patient’s per-
sonal life. Therefore, social and cultural needs should be 
assessed as these domains will undoubtedly influence the 
patient’s experience of symptoms. Social and cultural 
needs can also be associated with psychological distress. 
Additionally, social and cultural needs form part of people’s 
everyday existence, and they are therefore important to 
measure in their own right. Practical needs, such as organi-
sation of care or financial constraints, will add to patients’ 
burden, as can family dynamics and communication prob-
lems. A number of outcome measures cover practical and 
social needs. For example, the POS has one question on 
practical matters, the Distress Thermometer has five items 
on practical problems and the EORTC QLQ-C15-PAL 
includes one question on activities of daily living.
The measurement of spirituality is multi-faceted and 
includes meaning of life and death, transcendence and for-
giveness, as well as patients’ interpretation of their ill-
ness.42,43 Some outcome measures focus entirely on 
spirituality, whereas other tools include spirituality-related 
item(s) as part of assessing quality of life and religiosity. 
Spirituality is often overlooked when assessing a patient’s 
situation and can be easily missed in routine discussions. 
Using an outcome measure that includes at least one or 
two items relating to the spiritual dimension can help iden-
tify areas for further investigation and support. For exam-
ple, the POS includes a question about ‘feeling good about 
oneself’ and ‘whether life is worthwhile’, the African ver-
sion of the POS (APCA African POS) includes one ques-
tion on ‘feeling at peace’,44,45 the ESAS has one question 
on well-being,46 the Qual-E47 includes 3 (out of 31) items 
on spiritual aspects of quality of life and the McGill 
Quality of Life Questionnaire (MQOL) includes 4 (out of 
17) items on the meaning and purpose of life, life worth, 
feelings about oneself and value of life.48
Recommendation 3: Use outcome measures to assess 
the needs of unpaid caregivers (family and others) 
alongside the needs of patients
Carers and families often experience burden and have 
their own personal social, emotional and financial needs 
while caring for someone who requires palliative care. 
The substantial contribution that caregivers make to pal-
liative care has been recognised. At the same time, the 
lack of tools to assess the needs of unpaid caregivers is 
clear.49,50 Measuring their needs alongside the needs of 
patients can help clinicians develop more holistic care 
plans. This approach also recognises the role of unpaid 
caregivers as partners within the care process, and this 
matters to people.51
Outcome measures often focus on caregiver’s degree of 
burden and strain, especially their physical and mental 
health, finances and social life. Some measures examine 
the needs and experiences directly related to carer tasks, 
such as giving medication, providing physical care or 
managing time.52 Other instruments are designed for car-
ers of patients with specific diseases.
The Zarit Burden Inventory (ZBI) originally designed 
for carers of dementia patients has also been validated 
and used in relation to other conditions and in palliative 
care.53 The six-item version is widely used due to its 
potential to measure burden while also being brief.53 The 
POS includes one question on family anxiety26 and a 
question on information that includes the patient and 
family, the Cambridge Palliative Assessment Schedule 
(CAMPAS-R) has two items on carer anxiety and depres-
sion54 and the APCA African POS includes three questions 
on carer information, confidence and worry.44,45 Caring 
for a family member is also increasingly recognised as 
a positive rewarding task and not only as a negative 
burden.55
Recommendation 4: Use measures that have sound psy-
chometric properties
When choosing a measure, the psychometric properties, 
mainly validity and reliability, need to be considered to 
judge its quality. Validity is one of the most important 
aspects of an outcome measure.25 It refers to what a tool is 
measuring and whether it is measuring what it should 
be.56 Face and content, criterion and construct validity are 
the most important types of validity (see Appendix 1). 
Reliability refers to whether the measure produces the 
same or similar results when administered in unchanged 
conditions. High reliability is important as it can reduce 
measurement random error related to the measurement 
process. Reducing error helps improve accuracy and 
therefore results in a better evaluation of outcome. 
Consequently, patients may receive better care.
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Measures that are easy to use clinically but are not 
validated should be approached cautiously as there is no 
guarantee that they accurately assess the needs of patients 
or caregivers.
Recommendation 5: Use measures that are suited to 
the clinical task being delivered and also suited to the 
aims of your clinical work and the population you work 
with
Determining what needs to be measured and evaluating the 
usefulness of properties from a clinical perspective help to 
decide which measure is most suited to the clinical task and 
will work in a clinical setting. A large variety of outcome 
measures exist in palliative care.7 They differ in the domains 
and dimensions they measure, and in their length, measure-
ment window, accessibility and cost. This diversity makes 
the selection of one single measure challenging. It therefore 
helps to establish a clear goal for using the measure clini-
cally when selecting one.57 This includes considering the 
context in which the outcome measures will be used, for 
example, will the measure be routinely collected in clinical 
care once for screening or repeatedly over time to monitor 
changes?57 Will this information also be used for audit pur-
poses to help improve standards of care in a unit? For clini-
cal care, a short, widely accepted measure is recommended. 
Using single-item measures, such as for specific symptoms, 
is easier to interpret than multiple-item measures.58 
However, multiple-item scales allow for clinical description 
of patients, and this can be useful to individual healthcare 
professionals and multidisciplinary teams. Multiple-item 
measures help establish the profile of the patient using a 
common language among the team. They may also reassure 
service users that holistic care is provided. Finding the right 
tool for the clinical scenario and patient group is important. 
A balance between multiple-item and single-item measures 
may be necessary. For example, multiple-item tools can be 
complemented through add-on single-item measures. This 
approach ensures that problematic areas are investigated 
further and that benefits of single- and multiple-item meas-
ures are optimised. This enables both person-centred care 
responsive to needs and thorough investigation of more 
problematic items.
Considering what happens with the PRO scores and 
who will receive this information is important, for exam-
ple, the information may be discussed with the patients 
during therapy and also in multidisciplinary team meet-
ings.57,59 The effectiveness of this intervention may be 
facilitated by providing suggestions to clinicians on how 
to address issues identified by the PROMs.57,60
Recommendation 6: Use valid and reliable measures in 
research that are relevant to the research question and 
consider patient burden when using measures
Measures that are responsive to change over time and ones 
that capture clinically important data are important for 
research purposes. However, in research, a combination of 
different outcome measures is often necessary to answer 
the research question. To choose optimal measures, the tar-
get population, for example, patients or unpaid caregivers, 
must be considered. Also, the primary and secondary out-
comes of interest will determine measure selection.61 
Existing tools should be used rather than new tools devel-
oped as this takes considerable time (years), funds and 
resources. Using existing tools enables comparisons and 
helps build upon existing research knowledge for the field. 
Using existing measures therefore helps ensure the best 
use of research funds for the field of palliative care.9,62
For research, a battery of outcome measures is often 
used. This potentially burdens the patient with question-
naire fatigue especially towards the end of life.63 Therefore, 
careful consideration on which questions and items are 
required to address the research question is necessary. 
Considering which measures cover several areas or 
domains may also help to reduce overlap. Including ser-
vice users and clinicians in research advisory groups helps 
to discuss this and ensures research quality and relevance, 
and clinical, service-user and public engagement with the 
study.64
Recommendation 7: Use change management princi-
ples, facilitation and communication to embed outcome 
measurement into routine clinical practice and evalu-
ate the implementation process to ensure sustained use 
that penetrates practice within the organisation
Implementation of outcome measurement within organi-
sations requires change management, facilitation and 
communication. Outcome measurement within routine 
practice for screening and assessment leads to better 
symptom recognition, more discussion of quality of life 
and increased referrals based on reporting from outcome 
measurement.65 Outcome measures also help report on 
key mandatory performance indicators. Difficulties in 
using measures are clinical time constraints, concerns 
about patient burden, gate keeping by professionals, who 
can lead to sporadic use and therefore fragmented care, 
and a lack of training and guidance for staff in how to 
achieve outcome measurement.6 An example of success-
ful implementation of outcome measures in South Africa 
is shown in Appendix 1.
Understanding the factors, processes and forces that 
drive changes within colleagues and organisations aids the 
introduction and sustainability of outcome measurement 
into routine clinical care within services and organisations. 
Providing training and resources that address healthcare 
professionals’ concerns is key as is delivering bespoke 
training.66
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Outcome measurement implementation in organisa-
tions can be further aided through understanding the 
acceptance or reluctance to use outcome measures. For 
example, medical doctors and physiotherapists may be 
more inclined to accept and use outcome measures, as 
components of their work are directly related to dimen-
sions that are easily observed and measurable (e.g. range 
of movement, breathlessness). Other professionals, who 
focus on more phenomenological or psychological dimen-
sions such as social workers, spiritual counsellors and art 
therapists, may find it more challenging to embrace the use 
of outcome measures in their practice. For many health 
professionals, their core clinical training may not have 
addressed the need for the routine integration of outcome 
measurement within their practice. In order to overcome 
this challenge, team discussions about the value of meas-
urement may aid implementation and the facilitation of an 
organisational culture that is committed to measurement.
Identifying systems that can be put in place to make data 
collection, inputting and reporting processes easy will aid 
implementation. Achieving this will minimise the impact 
of measurement tasks on other duties. Support of key clini-
cal leaders and opinion leaders will aid the implementation 
of routine use of outcome measurement in palliative 
care, as will communicating key measurement findings. 
Communicating clinical improvements and trends may be 
of interest to healthcare providers. Aggregated findings 
regarding outcomes for services may be useful for manag-
ers. Commissioners may be interested in data across regions 
and services. The complexity of the patient group under 
consideration must be taken into account especially if the 
report is to be used for benchmarking of services.16 Clearly 
establishing the benefits of outcome measurement to patient 
care and embedding outcome measures within the systems 
and structures will help overcome the challenge of meas-
urement being perceived as an add-on burden by clinicians. 
Embedding outcome measurement into daily clinical care 
should eventually be invisible to the clinical team because 
it is so effectively instituted at a system, organisational and 
cultural level.
Recommendation 8: Relate outcome measurement to 
quality indicators (QIs)
Outcome measurement is integrally related to quality. 
However, QIs and outcome measures have to be distin-
guished clearly because both concepts are often wrong-
fully mistaken for one another. QIs are well defined and 
measure specific aspects of care or a related outcome and 
are expressed on an aggregated level such as a number or 
percentage of patients.67–70 Outcome measures are an 
essential component of quality but are measured on an 
individual level. Outcome measures can be used to calcu-
late QIs, but unlike QIs they do not allow for monitoring of 
care quality. However, QIs should reflect the outcomes 
that are relevant to patients, and these outcomes should 
then inform the QIs. QIs are effective tools for quick and 
efficient assessment of service performance at individual 
as well as institutional level. In a review of palliative care 
QIs, Pasman et al.71 found 145 indicators categorised into 
eight published sets. In all, 5 indicators covered structural 
quality, 82 described procedural quality and 57 described 
outcome quality.72 Based on these findings, a new QI set 
for palliative care has now been developed with 43 QIs 
mainly based on outcome.73
A major problem with the identification of QIs and with 
any individual indicator is that they are too narrow in 
focus. As a consequence, multiple indicators are often rec-
ommended as this will allow for a broader evaluation of 
the quality of care.74
Choosing measures that reflect outcomes that are rele-
vant to patients and families should also be suitable for 
the measurement of QIs. This implies that numerator, 
denominator and threshold values should be defined for 
each indicator. For benchmarking, audit or other quality 
improvement strategies, outcome indicators should be 
supplemented with indicators on procedural quality.75
Recommendation 9: Establish and use quality improve-
ment systems to sustain routine practice of outcome 
measurement and institute interoperable electronic sys-
tems to ensure integration of measures and across 
settings
Embedding outcome measurement into routine clinical 
practice can be helped through quality improvement ini-
tiatives such as audits.76 Audits can help identify major 
risks, reinforce implementation of evidence-based prac-
tice, influence improvements and ensure governance (or 
the accountability of services).
Where standards are not established, as may be the case 
for outcome measurement within certain countries or 
organisations, pre-audit activity can be completed to help 
establish standards. Pre-audit activity is similar to the 
usual audit cycle; however, instead of measuring perfor-
mance in relation to already established standards, the first 
step is identifying what standards are currently being 
achieved or are possible. The national outcome measure-
ment programme in Australia, PCOC, provides an example 
of how to approach benchmarking when agreed-upon 
standards are lacking.
Several initiatives have successfully implemented out-
come measurement in palliative care using tablet platforms 
and other devices. Symptom assessment by computers is 
feasible in patients with advanced cancer,77,78 and a cancer 
clinic using electronic patient-reported outcomes (ePROs) 
has demonstrated how real-time research quality data 
to support comparative effectiveness research can be 
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achieved.79 Ideally, when patients complete ePROs, data are 
automatically scored and available in easily interpretable 
reports to be viewed when the clinician meets with the 
patient.80 In Wales, palliative care services collect data 
required for the clinical care of patients including outcome 
data using the All Wales Specialist Palliative Care Data 
Set.81 The dataset is part of Cancer Network Information 
System Cymru (CaNISC), the online computer system 
holding information from a patient’s interactions with all 
health professionals in Wales.81 PCOC in Australia is 
a national voluntary programme utilising standardised 
validated clinical assessment tools in electronic records 
to benchmark and measure outcomes in palliative 
care.40 Also, the Outcome Assessment and Complexity 
Collaborative (OACC)82 is seeking to implement outcome 
measures into routine palliative care in South London.
Recommendation 10: Use measures that allow for com-
parisons across care settings and throughout Europe. 
Therefore, use measures that are culturally sensitive 
and have validated translations in relevant languages/
countries
As patients’ health status decline and their needs change, 
their place of care may also change. Using measures that 
allow for comparisons across palliative care settings aids 
care coordination, communication between providers and 
seamless transitions between care settings. Therefore, 
measures that can be used in various care settings are rec-
ommended. For example, POS has been validated in sev-
eral settings including hospitals, the community, nursing 
homes and hospices.26 This is further strengthened when 
the comparisons are adjusted for changes in patient charac-
teristics given the wide range of times and populations 
referred to palliative care services around the world. This 
should minimally include age, gender, diagnosis and aver-
age time before death.83
Cross-national comparisons are also important to 
advance palliative care internationally. For this to happen, 
outcome measures that have been translated into other lan-
guages, following a formal process and involving a rigor-
ous validation process, should be used.84 Although this is 
lengthy and costly,20 it is an important procedure to ensure 
accurate and comparable outcome measure data. Optimal 
translation involves the consideration of semantic and con-
ceptual meaning and procedures to ensure equivalence 
between cultures. Both forward and backward translations 
are important. Accuracy in translation also requires trans-
lating the sense of terms as words might have different 
meanings or connotations in different cultures. For exam-
ple, differences between the words in the Spanish and the 
Argentinean POS versions became apparent through cross-
cultural adaptation.85 A fine balance between accuracy and 
meaning needs to be achieved, as culture and language 
influence the approach, for example, to a symptom such as 
depression.86
Recommendation 11: Advance the field of palliative 
care through establishing national and international 
outcome collaborations that work towards benchmark-
ing to establish and improve care standards
Outcome measurement and benchmarking are a funda-
mental part of delivering comprehensive care.87 A key 
benchmarking consideration is the need to compare popu-
lations of different services given that the time of referral, 
the proportion of people with a life-limiting illness referred 
and the proportion of various diagnoses of life-limiting ill-
nesses vary by service.88 Diagnosis alone is not predictive 
of the care that is needed or of the time before death or 
referral.83 A common language to describe the palliative 
care population being studied is therefore required. This 
language must include functionality and case-mix adjust-
ment. Case-mix adjustment allows comparison of any 
residual outcome differences to focus on models of care 
and funding as potential key drivers of variations.40
Once the challenges of functionality and case-mix 
adjustment have been addressed, the process of engaging 
local services to participate in benchmarking becomes 
paramount alongside the consideration of funding and ser-
vice configuration.16,89 In Europe, each provider is likely 
to have their own evaluation of care quality and potentially 
their own outcome measures. Therefore, comparison 
across providers is difficult if there are no agreed ways of 
describing the patient clinically. Agreeing on a set of out-
come measures can help overcome this challenge. Second, 
the funding and structures of services are not standardised 
within or between health systems. By definition, this 
means that comparison needs to be at the level of patients 
and not at a service level. Variations in patient outcomes 
can then potentially be linked to differences in the models 
of service provision, the levels of funding or both. This 
should be linked to QI performance.
Recommendation 12: To improve and monitor pallia-
tive care, practice policy makers should recommend 
routine collection of outcome data, and then these data 
should be used to establish a minimum dataset of pal-
liative care outcome measures in order to improve and 
advance clinical care and research
Healthcare systems across the world are facing major chal-
lenges in the form of rising demand and costs. Policy mak-
ers should recommend routine collection and then ensure 
that these data are used on a patient and service level as 
suggested in the Strategic Directions of the State of 
Victoria/Australia where palliative care services are 
encouraged to participate in national palliative care 
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outcomes and standard assessment processes.90 Besides 
the commitment to collect routine outcome data, profes-
sional bodies should establish a minimum dataset of core 
measures or domains that are used and accepted on a 
national and ideally international level. National and 
regional recommendations have the potential to advance 
the evidence base through the possibility of stronger com-
parisons and meta-analyses of the impact of treatments, 
services and policies in palliative care.
Discussion
This White Paper proposes 12 recommendations for out-
come measurement in palliative care. These cover key 
parameters of measures, adequate measures for the task, 
introduction of outcome measurement into practice, and 
national and international outcome comparisons and bench-
marking. Compared to other outcome measurement recom-
mendations, for example, MORECare11 or ISOQOL,13,91 
the EAPC White Paper covers similar aspects but focuses 
more on outcome measurement in clinical care and the 
wider policy impact of implementing outcome measure-
ment in clinical palliative care. As PROM feedback 
improves awareness of unmet need and allows profession-
als to act to address patients’ needs, this seems to be of high 
importance.65 However, a number of barriers and facilita-
tors have been identified when implementing outcome 
measurement in clinical care that should be addressed.66
Within Europe, palliative care continues to meet the 
challenges associated with patients living longer, increased 
incidence and prevalence of many long-term conditions, 
and new treatments that extend life.92,93 Although different 
models of care will be necessary in different European 
countries, they will all need to demonstrate improvement 
in patient outcomes. Individual patient-reported data are 
essential to substantiate the clinically meaningful differ-
ence palliative care makes. Outcome measurement is key 
to understanding different models and commonalities of 
care across countries and patient complexity. Outcome 
data are also essential to quality improvement, benchmark-
ing and comparisons within Europe. In order to advance 
the region of Europe, we need to use existing tools and 
avoid the risk of investing in the development of new 
measures.6,7 Adequate implementation strategies, includ-
ing education interventions, are required. With improve-
ments in technologies and computing, the opportunities to 
simply collect and analyse outcome data and to use these 
to generate outcome and QIs increase. These advances 
complement gains to patient care that are possible through 
routine use of outcome measurement in clinical practice. 
Centres of excellence for outcome measurement within 
Europe could aid the further development and provide 
resources for training and further research. We should 
invest in national outcome collaboratives as the potential 
gains are great, as has been demonstrated in Canada and 
Australia. It is time now to also achieve this in Europe, and 
whether or not this happens may be an ultimate measure of 
palliative care within the EU.
This White Paper has several strengths and limitations. 
It builds on extensive work of international projects bring-
ing together experts from a wide clinical and research 
background. This includes literature searching, an online 
survey and an international expert workshop. The paper is 
therefore the result of a long process, which started infor-
mally long before the Task Force on outcome measure-
ment took up its work. Limitations are that no formal 
consensus process was followed to agree on the recom-
mendations and content of the White Paper. It could be 
argued that a formal Nominal Group Technique or Delphi 
process would have been preferable. These techniques are 
helpful when some group members are more vocal than 
others, when there is concern that some may not partici-
pate, when there are power imbalances and when more 
unique ideas need to be generated.94 In developing this 
White Paper, we used a combination of electronic com-
menting on drafts, after initial face-to-face ‘brainstorm-
ing’ meetings, to allow for a more equal participation and 
exchange of ideas. However, we did not progress to for-
mal ranking of recommendations, as in some consensus 
papers.95 We therefore regard this work as a starting point, 
on which others may build.
Conclusion
Our recommendations for outcome measurement in pallia-
tive care propose that measures should be well validated 
for the population in which they are to be used, fit for use 
in clinical care as well as research. The White Paper rec-
ommends the introduction of outcome measurement into 
practice and outcomes that allow for national and interna-
tional comparisons and benchmarking. This is key to 
understanding different models and commonalities of care 
across countries and patient complexity. Centres of excel-
lence for outcome measurement within Europe could aid 
further development and provide resources for training 
and further research.
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Appendix 1
The following material is provided in an appendix: examples of multidimensional outcome measures in palliative care, 
outcome measurement in specific groups, psychometric properties of outcome measures, example of successful imple-
mentation of outcome measures in South Africa and considerations of use of outcome measures in low-to-middle income 
countries (e.g. Eastern European countries, Africa)
Appendix White Paper on outcome measurement in palliative care
Outcome measurement in specific groups
Outcome measurement in children
Most validated outcome measures are designed for the adult palliative care population; however, it is important to consider 
the need for measuring outcomes in children receiving palliative care as well as adults. Outcome measurement in children 
poses specific challenges as they need to be specific to age and cognitive functioning. Measures that can be used by par-
ents and siblings should also be considered. A recent report on the status of palliative care for children in sub-Saharan 
Africa noted that in order to begin to measure and improve the care of children, multidimensional tools that capture the 
needs and priorities of African children and their families, and approaches to scoring using appropriate methods are 
urgently required for development and full validation.97 A review of the literature identified a variety of uni-dimensional 
Table 2. Examples of multidimensional outcome measures in palliative care.
Name of outcome measure Number of items Time for completion Additional comments
Edmonton Symptom 
Assessment Scale (ESAS)27
9 symptoms + 1 ‘other problem’ Approximately 5 min Each symptom with NRS 0–10 
developed to measure the 
most commonly experienced 
symptoms in cancer patients, 
available in a wide range of 
languages, broadly validated
Palliative care Outcome 
Scale (POS)26
10 items on physical symptoms, 
emotional, psychological and 
spiritual needs, provision of 
information and support
1 open question on main 
problems
Mean time 6.9 min (patients) 
and 5.7 min (staff); repeated 
assessments of patients and 
staff mean time <4 min
Scores from 0 (no effect) to 4 
(overwhelming)
Patient, staff and carer version
Widely used palliative care 
measure
POS Symptom list (POS-S)
 
 
POS-S: 10 symptoms; 2 questions 
about the symptom that affected 
the patient the most and that has 
improved the most
Additional symptom versions 
available for other conditions 





28 physical and 4 psychological 
symptoms
20–60 min, short form 
<5 min
Measuring presence, 
frequency, severity and 
distress of symptom
Short-form version available 
(MSAS-SF): only presence and 
distress of symptom
Developed for cancer patients 





20 symptoms, 5 items on 
practical problems, 4 on family 
problems, 5 on emotional 
problems, 2 on spiritual concerns
Median length of time 5 min, 
with 75% taking no more 
than 10 min
Distress score 0–10, other 
items yes/no
 
EORTC QLQ-C15-PAL Pain, physical function (3 items), 
emotional function (2 items), 
fatigue (2 items) quality of life (1 
item), symptoms (6 items)
<20 min Copyrighted instrument, 
supplement version of the 
EORTC QLQ-C30 for 
palliative care patients
NRS: numerical rating scales; SF: Short Form.
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tools for use in children including those for pain assessment98–100 and quality of life,101 but no multidimensional outcome 
tools for palliative care in children were identified. However, work in this area has begun. For example, work on the 
development of an APCA African Children’s POS (APCA African C-POS) as a multidimensional outcome measurement 
that can be used to measure the holistic outcomes of children’s palliative care provision has commenced.102
Outcome measurement in patients with dementia
Outcome measurement for patients with dementia poses different challenges on carers. In elderly people with mild cogni-
tive impairment, patient-reported outcome measurement is feasible, but these people are normally not near the end of life. 
Increasing cognitive impairment and physical dependence may indicate that a palliative care approach is appropriate. 
However, outcome measurement then becomes very challenging. It has been questioned whether measurement of psycho-
logical, social and spiritual concerns is reliable at all in advanced dementia patients. Physical symptoms need to be 
assessed by observation of clinical signs, but evaluation of social and spiritual needs depends on information collected 
years before without clear evidence whether these are still reliable.
Psychometric properties of outcome measures
Validity
Validity is one of the most important aspects of an outcome measure.25 It refers to what a tool is measuring and whether it 
is measuring what it should be.56 The most important types of validity are face and content, and criterion and construct.
Face and content validity are closely linked concepts that describe whether a measure is assessing the relevant aspects 
required and whether the content covered is appropriate, important, sufficient,25 non-redundant and clear. The quality 
criteria for these two areas are not standardised, and assessment is usually based on the subjective views of patients, family 
carers and/or healthcare professionals. This is particularly important for palliative care as patients and families are the 
centre of care and therefore the experts of their situation.
Face and content validity are of central importance to the choice of PROMs for routine clinical practice as they high-
light the extent to which the measure captures the views of patients and other key stakeholders.103
Criterion validity refers to how the measure correlates with another instrument that measures similar aspects. Preferably, 
the other instrument would be the ‘gold standard’, meaning it has been validated and is widely used and accepted regard-
ing the measure under consideration. For a new measure, the correlation with the ‘gold standard’ is expected to be between 
0.4 and 0.8 for it to have an acceptable criterion validity.56 If no other measure or gold standard exists for comparison, the 
measure must nevertheless be linked to a theory or hypotheses in order to show construct validity.
Construct validity is the degree to which the scores are consistent with hypotheses, for example, with regard to internal 
relationships, relationships with scores of other instruments or differences between relevant groups.104 Construct validity 
covers three aspects: structural validity which is tested through factor analyses; hypotheses testing, for example, compari-
son with other measures; and cross-cultural validity including translations and comparing scores in different countries.17 
This includes correlation with socio-demographic indicators, severity of the disease and other biological indicators. In 
hypothesis testing, three aspects of construct validity can be tested: convergent validity (e.g. if items in two measures 
assessing the same thing are indeed correlated), divergent validity (e.g. if items in two measures assessing different things 
are NOT correlated) and predictive validity (that the measure predicts a future relevant outcome or event, such as survival 
for functional status measures). If the relationship between the measure and theory that it is testing cannot be shown, the 
problem can rest with the measure or with the theory used.
Validity and reliability are related. If a measure is found to be valid, it must also have a good degree of reliability. 
However, a measure can be reliable yet not valid (e.g. because it is measuring the wrong thing, albeit reliably).105
Reliability
The reliability of an outcome measure refers to whether the measure produces the same or similar results when adminis-
tered in unchanged conditions. High reliability is important as it can reduce measurement random error or non-random 
errors that are related to the process of measurement. Reducing error is important as it helps improve the accuracy of the 
measurement and therefore results in a better evaluation of the patient’s health status and outcome. Steps can be taken to 
improve the reliability of measures, for example, by providing clear definitions of the scores to be used.
Inter-rater reliability assesses whether similar results are reached when different observers are used to rate the same 
situation or patient. Normally, inter-rater reliability is calculated with Cohen’s kappa, which takes into account the propor-
tion of agreement between the two raters in relation to the proportion of responses that could be expected by chance.56 
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Cohen’s kappa can have a value between 0 and 1, with levels of 0.21–0.4 indicating fair agreement; 0.41–0.6 moderate 
agreement and 0.61–0.8 substantial agreement.106 Intra-rater reliability, another important component of reliability, 
measures the reliability within the same individual completing the measurement repeatedly.
Test–re-test reliability assesses whether similar results are reached over two distinct periods of time in unchanged con-
ditions. The time intervals chosen depend on the variability of the domain being measured and the potential for change 
over time.107 The test–re-test reliability can be assessed by Cohen’s kappa statistical test, which is controlling for chance 
agreement.25 In some circumstances, the correlation coefficient may also be used.
Internal consistency evaluates how individual items of the outcome measure correlate with each other. The quality 
criterion to assess internal consistency is Cronbach’s alpha, which reports the average of correlations between all possible 
halves of the scale.25 A very high internal consistency (>0.9) suggests that many items of the measure are capturing simi-
lar aspects.25 Internal consistency is important if an outcome measure is used to monitor a single underlying concept with 
multiple items. However, if the underlying clinical phenomenon is complex or multifactorial and do not have to be cor-
related, internal consistency is not relevant.108
Appropriateness and acceptability
Many PROMs have been primarily developed for use in research, with the emphasis on psychometric properties. However, 
a psychometrically sound measure may not always be very practical for clinical use. Therefore, appropriateness and accept-
ability are used to indicate whether a measure is suitable for its intended use.25 Barriers for use in clinical care include 
measures that are too long for patients to answer or that require a lot of time or equipment for administration, complicated 
scoring systems, costs related to the use of the measure or poor accessibility (i.e. they may not be fully published, fully 
available or access may be restricted). These aspects are particularly important in the context of palliative care, where 
patients are cared for in different settings, such as at home, in hospital or in a hospice; patients’ time is limited; and their 
condition, which may involve cognitive impairment and progressive frailty, poses a challenge to the use of outcome meas-
urement. Therefore, there needs to be a balance between sound psychometrics and the feasibility of a measure for clinical 
use, otherwise referred to as the measure’s clinimetric properties.
Measures that are easy to use clinically but are not validated should be approached cautiously as there is no guarantee 
that they are accurately assessing the needs of patients and their caregivers.
Responsiveness to change
Responsiveness to change refers to whether the measure can detect clinically important changes over time that are 
related to the course of the disease or to an intervention, such as symptom management. This is particularly important in 
outcome measurement as, by definition, outcomes are related to change, whereas assessment of health status is related 
to a particular point in time.103 The quality criteria to assess responsiveness to change are multiple. They include com-
parison of the change detected by the outcome measure with the change measured by a ‘gold standard’ and comparison 
with what the patient or clinician has identified as an important change or association of detected change with changes 
in treatment or care.25 When an outcome measure has proven to be responsive to change, the minimally clinically impor-
tant difference (MCID) needs to be determined. The MCID is defined as the smallest change or difference in an outcome 
measure that is perceived as beneficial by or to the patient.109 This change can either be identified by asking patients 
about differences or by calculating it using mathematical criteria.110 MCIDs are available for many measures, but, in 
general, a difference of about one half of the standard deviation of the endpoint being assessed is a useful and surpris-
ingly reproducible estimate.110
Interpretability
The interpretability of an outcome measure refers to whether the results (which are often a number) can be translated into 
something more meaningful to the patient/family or clinician. An interpretable tool should enable a response to these ques-
tions: What is severe? What is the cut-off point when the outcome measure is used for diagnosis? How many points cor-
relate with a symptom change?25 One important tool for the interpretability of a PROM’s score is the normative distribution 
of this measure taking into account that the sample is representative of the population, meaning that the patients in the 
sample have similar characteristics to the wider population cared for. One important tool for the interpretability of a 
PROM’s score is the norms of this measure which are established for a representative population. The individual patient 
scores are then compared to the norm to find out whether the patient is below/above the norm.
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Example of successful implementation of outcome measures in South Africa
The Hospice Palliative Care Association (HPCA) has encouraged and supported its members in the use of the APCA 
African POS since its validation as an Audit Tool.44,45 This has led to quality improvement activities such as the 
following:
•• Restructuring programmes so that scarce professional resources are optimally used with regard to the coordination 
of pain and symptom control;
•• Creating additional psycho-social posts to address the level of worry identified in patients and families;
•• Conducting clinical audits to develop better protocols to manage pain and other distressing symptoms.
Using a validated audit tool to improve the quality of care has been included as a criterion in the Quality Management 
and Improvement service element in the second edition of the Hospice Palliative Care Standards.58
During 2010 as part of a donor-funded project, the APCA African POS was used to assess the collective difference 
made by 50 home-based care programmes to patient and family outcomes. The University of Cape Town analysed 336 
questionnaires. The following statistically significant examples of results of care were documented. Each question had a 
response rate ranging from 0 to 5:
•• Pain scores dropped from an average of 4 on visit 1 to an average of 1 on visit 6 (p ⩽ 0.001).
•• Scores for level of worry identified by the patient dropped from 4 to 1 (p ⩽ 0.001).
•• Scores reflecting the family’s confidence in caring for the patient increased from 3 to 5 (p ⩽ 0.001).
This evidence of holistic care by member organisations has provided HPCA with a powerful advocacy tool.
The APCA African POS was used to assess the provision of care within organisations funded by the Global Fund in the 
Western Cape. It is also the evaluation tool in the current research study looking at how palliative care is part of the right 
to health, and it will be used to assess the outcomes of care in tuberculosis (TB) patients in KwaZulu-Natal.
Considerations of use of outcome measures in low- to middle-income countries 
(e.g. Eastern European countries, Africa)
The majority of outcome measures have been developed for resource-rich settings, with little work being done to support 
an understanding of the use of outcome measures in resource-limited settings.111 However, individuals living in resource-
limited settings have the right to receive best quality palliative care, with appropriate measures to assess outcomes in order 
to achieve this goal.4,44 Recently, work done in Africa has been a good example of multi-centre, regional and international 
collaboration, in the development of the APCA African POS44,45 and the APCA African Children’s POS.112 The APCA 
African POS is based on the POS but underwent cultural adaptation with slight changes in the structure (seven patient-
oriented and three informal carer–oriented questions), the answer options and an additional question on feeling at peace.44
Work done in resource-limited settings, such as the Dominican Republic, Cambodia,111 within Africa44,45,113,114 and cur-
rently in Eastern Europe, demonstrates that it is possible to develop, adapt and utilise outcome measures effectively in 
resource-limited settings. Research into the use of the APCA African POS, which was developed out of an absence of 
outcome measures validated for the African setting,45,115 has identified key issues that need to be considered when devel-
oping or adapting an outcome measure for use in resource-limited settings. These include the following: the importance 
of having locally validated tools; tools that are easy to use and enable health workers to elicit information from the patients 
that will help improve the care they give; tools that are clearly laid out, specific and include both the patient and the family; 
and tools that are not too long, with the ideal tool being seen as between 6 and 15 questions, which cover all dimensions 
of palliative care.9,113
Essential to the successful implementation of outcome measures in resource-limited settings is the recognition of their 
role in palliative care, both clinically, for research and quality improvement.6 Tools will need to be adaptable to the setting 
and used by volunteers as appropriate.113,114 Training and guidance on the use of tools and how to analyse data are key, with 
challenges identified such as a lack of training, language barriers, time constraints, literacy levels and complexities of the 
tools.113 However, despite these challenges, there is evidence to show that outcome tools, specifically the APCA Africa 
POS, are being used in many resource-limited settings across Africa. National, regional and international collaborations to 
share concepts, experiences and solutions can support the introduction of outcome measures9 into resource-limited settings, 
and allocation of resources and provision of care should be guided by locally generated and relevant evidence.44
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